{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:02:50Z","timestamp":1784350970203,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Agency for Defense Development, Republic of Korea","award":["UD180041GD"],"award-info":[{"award-number":["UD180041GD"]}]},{"name":"Agency for Defense Development, Republic of Korea","award":["211555-912664201"],"award-info":[{"award-number":["211555-912664201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12033-023-00800-4","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T07:02:27Z","timestamp":1688972547000},"page":"1718-1726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Post-Vaccination Delivery of CpG ODNs Enhances the Th2-Associated Protective Immunity of the Smallpox DNA Vaccine"],"prefix":"10.1007","volume":"66","author":[{"given":"Min Hoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Seok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euni","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyoul","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ho","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyueng Haeng","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-2284","authenticated-orcid":false,"given":"Sungho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1099\/vir.0.82708-0","volume":"88","author":"A Garcel","year":"2007","unstructured":"Garcel, A., Crance, J. M., Drillen, R., Garin, D., & Favier, A. L. (2007). Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses. Journal Of General Virology, 88, 1906\u20131916.","journal-title":"Journal Of General Virology"},{"key":"800_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/v12020138","volume":"12","author":"H Meyer","year":"2020","unstructured":"Meyer, H., Ehmann, R., & Smith, G. L. (2020). Smallpox in the post-eradication era. Viruses, 12, 138.","journal-title":"Viruses"},{"key":"800_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1128\/AEM.02167-07","volume":"74","author":"R Sinclair","year":"2008","unstructured":"Sinclair, R., Boone, S. A., Greenberg, D., Keim, P., & Gerba, C. P. (2008). Persistence of category a select agents in the environment. Appl Environ Microbio, 74, 555\u2013563.","journal-title":"Appl Environ Microbio"},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1016\/j.vaccine.2009.07.103","volume":"27","author":"RB Kennedy","year":"2009","unstructured":"Kennedy, R. B., Ovsyannikova, I., & Poland, G. A. (2009). Smallpox vaccines for biodefense. Vaccine, 27, D73\u2013D79.","journal-title":"Vaccine"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4161\/hv.21080","volume":"8","author":"PH Verardi","year":"2012","unstructured":"Verardi, P. H., Titong, A., & Hagen, C. J. (2012). A vaccinia virus renaissance; new vaccine and immunotherapeutic uses after smallpox eradication. Hum Vaccines Immunother, 8, 961\u2013970.","journal-title":"Hum Vaccines Immunother"},{"key":"800_CR6","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/v7041726","volume":"7","author":"L Sanchez-Sampedro","year":"2015","unstructured":"Sanchez-Sampedro, L., Perdiguero, B., Mejias-Perez, E., Garcia-Arriaza, J., Pilato, M. D., & Esteban, M. (2015). The evolution of poxvirus vaccines. Viruses, 7, 1726\u20131803.","journal-title":"Viruses"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1586\/erv.11.46","volume":"10","author":"JW Golden","year":"2011","unstructured":"Golden, J. W., & Hooper, J. W. (2011). The strategic use of novel smallpox vaccines in the post-eradication world. Expert Review Of Vaccines, 10, 1021\u20131035.","journal-title":"Expert Review Of Vaccines"},{"key":"800_CR8","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3390\/ijms19113605","volume":"19","author":"D Hobernik","year":"2018","unstructured":"Hobernik, D., & Bros, M. (2018). DNA vaccines-how far from clinical use. International Journal Of Molecular Sciences, 19, 3605.","journal-title":"International Journal Of Molecular Sciences"},{"key":"800_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","volume":"19","author":"S Rauch","year":"2018","unstructured":"Rauch, S., Jansy, E., Schmidt, K. E., & Petsch, B. (2018). New vaccine technologies to combat outbreak situations. Frontiers In Immunology, 19, 1963.","journal-title":"Frontiers In Immunology"},{"key":"800_CR10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1586\/erv.09.132","volume":"8","author":"LC Dupuy","year":"2009","unstructured":"Dupuy, L. C., & Schmaljohn, C. S. (2009). DNA vaccines for biodefense. Expert Review Of Vaccines, 8, 1739\u20131754.","journal-title":"Expert Review Of Vaccines"},{"key":"800_CR11","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","volume":"78","author":"JW Hooper","year":"2004","unstructured":"Hooper, J. W., Thompson, E., Wilhelmsen, C., Zimmerman, M., Ichou, M. A., Steffin, S. E., Schmaljohn, C. S., Schmaljohn, A. L., & Jahrling, P. B. (2004). Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. Journal Of Virology, 78, 4433\u20134443.","journal-title":"Journal Of Virology"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","volume":"377","author":"JW Golden","year":"2008","unstructured":"Golden, J. W., & Hooper, J. W. (2008). Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology, 377, 19\u201329.","journal-title":"Virology"},{"key":"800_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","volume":"371","author":"P Sakhatskyy","year":"2008","unstructured":"Sakhatskyy, P., Wang, S., Zhang, C., Chou, T., Kishko, M., & Lu, S. (2008). Immunogenicity and protection efficiency of subunit-based smallpox vaccines using variola major antigens. Virology, 371, 98\u2013107.","journal-title":"Virology"},{"key":"800_CR14","doi-asserted-by":"publisher","first-page":"e0123113","DOI":"10.1371\/journal.pone.0123113","volume":"10","author":"O Martinez","year":"2015","unstructured":"Martinez, O., Miranda, E., Ramirez, M., Santos, S., Rivera, C., Vazquez, L., Sanchez, T., Tremblay, R. L., Rios-Olivares, E., & Otero, M. (2015). Immunomodulator-based enhancement of anti smallpox immune responses. PLoS One, 10, e0123113.","journal-title":"PLoS One"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2157-2526.1000155","volume":"8","author":"NY Kim","year":"2017","unstructured":"Kim, N. Y., Chang, D. S., Hur, G. H., Lee, T. Y., Yang, J. M., & Shin, S. (2017). Immunogenicity and protective efficiency in mice of a smallpox DNA vaccine candidate. J Bioterr Biodef, 8, 2.","journal-title":"J Bioterr Biodef"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21775\/cimb.022.017","volume":"22","author":"L Li","year":"2017","unstructured":"Li, L., & Petrovsky, N. (2017). Molecular adjuvants for DNA vaccines. Current Issues In Molecular Biology, 22, 17\u201340.","journal-title":"Current Issues In Molecular Biology"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","volume":"80","author":"J Lee","year":"2018","unstructured":"Lee, J., Kumar, S. H., Jhan, Y. Y., & Bishop, C. J. (2018). Engineering DNA vaccines against infectious diseases. Acta Biomaterialia, 80, 31\u201347.","journal-title":"Acta Biomaterialia"},{"key":"800_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coi.2020.08.008","volume":"65","author":"SG Reed","year":"2020","unstructured":"Reed, S. G., Tomai, M., & Gale, M. J. (2020). New horizons in adjuvants for vaccine development. Current Opinion In Immunology, 65, 97\u2013101.","journal-title":"Current Opinion In Immunology"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics13020142","volume":"13","author":"M Luncher","year":"2021","unstructured":"Luncher, M., Reinke, S., & Milicic, A. (2021). TLR agonists as vaccine adjuvants targeting cancer and infectious diseases. Pharmaceutics, 13, 142.","journal-title":"Pharmaceutics"},{"key":"800_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/vaccines2020323","volume":"2","author":"DNA Toussi","year":"2014","unstructured":"Toussi, D. N. A., & Massari, P. (2014). Immune adjuvant effect of molecularly toll-like receptor ligands. Vaccines, 2, 323\u2013353.","journal-title":"Vaccines"},{"key":"800_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S2213-2600(21)00402-1","volume":"9","author":"SM Hsieh","year":"2021","unstructured":"Hsieh, S. M., Liu, M. C., Chen, Y. H., Lee, W. S., Hwang, S. J., Cheng, S. H., Ko, W. C., Hwang, K. P., Wang, N. C., Lee, Y. L., Lin, Y. L., Shih, S. R., Huang, C. G., Liao, C. C., Liang, J. J., Chang, C. S., Chen, C., Lien, C. E., Tai, I. C., & Lin, T. Y. (2021). Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: Interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. Lancet Respir Med, 9, 1396\u20131406.","journal-title":"Lancet Respir Med"},{"key":"800_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10529-017-2497-9","volume":"40","author":"Z Panahi","year":"2018","unstructured":"Panahi, Z., Abdoli, A., Mosayebi, G., Mahdavi, M., & Bahrami, F. (2018). Subcutaneous administration CpG-ODN act as a potent adjuvant for an HIV-1-tat based vaccine candidate to elicit cellular immunity in BALB\/c mice. Biotechnology Letters, 40, 527\u2013533.","journal-title":"Biotechnology Letters"},{"key":"800_CR23","doi-asserted-by":"publisher","first-page":"109953","DOI":"10.1016\/j.vetimm.2019.109953","volume":"218","author":"H Chen","year":"2019","unstructured":"Chen, H., Yan, M., Tang, Y., & Diao, Y. (2019). Evaluation of immunogenicity and protective efficiency of a CpG-adjuvanted DNA vaccine against Tembusu virus. Veterinary Immunology And Immunopathology, 218, 109953.","journal-title":"Veterinary Immunology And Immunopathology"},{"key":"800_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/eji.201242690","volume":"43","author":"Y Yu","year":"2013","unstructured":"Yu, Y., Li, N., Ma, Y., Wang, S., Yu, W., & Sun, Z. (2013). Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants. European Journal Of Immunology, 43, 228\u2013239.","journal-title":"European Journal Of Immunology"},{"key":"800_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/14760584.2014.863715","volume":"13","author":"H Shirota","year":"2014","unstructured":"Shirota, H., & Klinman, D. M. (2014). Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Review Of Vaccines, 13, 299\u2013312.","journal-title":"Expert Review Of Vaccines"},{"key":"800_CR26","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","volume":"32","author":"J Scheiermann","year":"2014","unstructured":"Scheiermann, J., & Klinman, D. M. (2014). Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. Vaccine, 32, 6377\u20136387.","journal-title":"Vaccine"},{"key":"800_CR27","first-page":"454","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran, B., Arunachalam, P. S., & O\u2019Hagan, D. T. (2021). Emerging concepts in the science of vaccine adjuvants. Nature Rev, 20, 454\u2013475.","journal-title":"Nature Rev"},{"key":"800_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/v9120378","volume":"9","author":"S Reeman","year":"2017","unstructured":"Reeman, S., Gates, J. A., Pulford, D. J., Krieg, A., & Ulaeto, D. O. (2017). Protection of mice from lethal vaccinia virus infection by vaccinia virus protein subunits with a CpG adjuvant. Viruses, 9, 378.","journal-title":"Viruses"},{"key":"800_CR29","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1128\/JVI.01854-07","volume":"82","author":"A Berhanu","year":"2008","unstructured":"Berhanu, A., Wilson, R. L., Watts, K., King, D. S., Warren, T. K., Lund, S. A., Brown, L. L., Krupkin, A. K., VanderMay, E., Weimers, W., Honeychurch, K. M., Grosenbach, D. W., Jones, K. F., & Hruby, D. E. (2008). Vaccination of Balb\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. Journal Of Virology, 82, 3517\u20133529.","journal-title":"Journal Of Virology"},{"key":"800_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/14760584.2016.1175305","volume":"15","author":"EA Voigt","year":"2016","unstructured":"Voigt, E. A., Kennedy, R. B., & Poland, G. A. (2016). Defending against smallpox: A focus on vaccines. Expert Review Of Vaccines, 15, 1197\u20131211.","journal-title":"Expert Review Of Vaccines"},{"key":"800_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-0716-0872-2_4","volume":"2197","author":"N Kayraklioglu","year":"2021","unstructured":"Kayraklioglu, N., Horuluoglu, B., & Klinman, D. M. (2021). CpG oligonucleotides as vaccine adjuvant. Methods In Molecular Biology, 2197, 51\u201385.","journal-title":"Methods In Molecular Biology"},{"key":"800_CR32","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1016\/S0264-410X(02)00238-4","volume":"20","author":"Y Kojima","year":"2002","unstructured":"Kojima, Y., Xin, K., Ooki, T., Hamajima, K., Oikawa, T., Shinoda, K., Ozaki, T., Hoshino, Y., Jounal, N., Nakazawa, M., Klinman, D., & Okuda, K. (2002). Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine, 20, 2857\u20132865.","journal-title":"Vaccine"},{"key":"800_CR33","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","volume":"25","author":"CN Fong","year":"2007","unstructured":"Fong, C. N., Americo, J. L., Lustig, S., Huggins, J. W., Smith, S. K., Damon, I., Resch, W., Earl, P. L., Klinman, D. M., & Moss, B. (2007). Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus. Vaccine, 25, 2787\u20132799.","journal-title":"Vaccine"},{"key":"800_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/eji.200324032","volume":"34","author":"J Vollmer","year":"2004","unstructured":"Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., & Krieg, A. M. (2004). Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. European Journal Of Immunology, 34, 251\u2013262.","journal-title":"European Journal Of Immunology"},{"key":"800_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Sender","year":"2008","unstructured":"Sender, R. A., Darrah, P. A., & Roederer, M. (2008). T cell quality in memory and protection: Implications for vaccine design. Nature Reviews Immunology, 8, 247\u2013258.","journal-title":"Nature Reviews Immunology"},{"key":"800_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00705-002-0935-y","volume":"148","author":"JJ Putlitz","year":"2003","unstructured":"Putlitz, J. J., Stremmel, P. W., & Wands, J. R. (2003). CpG immune-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization. Archives Of Virology, 148, 435\u2013448.","journal-title":"Archives Of Virology"},{"key":"800_CR37","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.4049\/jimmunol.181.8.5785","volume":"181","author":"D Tross","year":"2008","unstructured":"Tross, D., & Klinman, D. M. (2008). Effect of CpG oligonucleotides on vaccine-induced B cell memory. The Journal Of Immunology, 181, 5785\u20135790.","journal-title":"The Journal Of Immunology"},{"key":"800_CR38","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.4049\/jimmunol.178.4.2415","volume":"178","author":"A Jegerlehner","year":"2007","unstructured":"Jegerlehner, A., Maurer, P., Bessan, J., Hinton, H. J., Kopf, M., & Bachmann, M. (2007). TLR9 signaling in B cells determines class switch recombination to IgG2a. The Journal Of Immunology, 178, 2415\u20132420.","journal-title":"The Journal Of Immunology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00800-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00800-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00800-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:43:19Z","timestamp":1719844999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00800-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00800-4","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Na Young Kim, Euni Sim, Jun Young Choi, and Young Kee Shin currently hold stock and Min Hoon Lee, Hong Seok Choi, Na Young Kim, and Jun Young Choi hold stock options in ABION Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal studies were conducted under protocols approved by the Institutional Animal Care and Use Committee of Institution (approval ID: SNU001254, IACUC SNU-190325-1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}